“…In the right column, the nerve signal decay is shown for the three sequences with the corresponding T2 fit incorporating all available TEs (black dotted line) or matched TEs (green dashed line). When the TEs are matched, a good agreement between magnetic resonance spectroscopy (MRS) and the 3D T2-prepared TSE sequence can be seen, whereas the T2 in the 2D MESE sequence is elevated regardless of TE selection or iatrogenic injury and tumors such as perineuriomas [5][6][7][8], Fabry disease [9][10][11], CMTD [12], or diabetic and other neuropathies [13,14]. Importantly, (semi-)quantitative MRN might be more objective and potentially more robust and reproducible when compared to mere qualitative MRN, with DTI, for instance, being capable of contributing with quantitatively assessable changes by means of diffusion parameters that have already been evaluated among patients with muscular disorders such as myotonic dystrophy [15], radiculopathy [16], CIDP [17], CMTD [18], or different Fig.…”